Roche has launched the cobas eplex RP3 panel for CE-markets, enabling simultaneous detection of up to 25 respiratory pathogens with customizable configurations, according to the company.
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
ViewsML will present an AI platform at USCAP 2026 that predicts biomarker expression from standard H&E slides, enabling per-cell spatial analysis without additional staining, according to the company.
The Vizient Innovative Technology Program evaluates products submitted through client-led councils for their potential to improve clinical care, patient safety, and business operations.
The approval makes MyChoice CDx the sole FDA-approved test in the US to identify HRD-positive patients eligible for niraparib maintenance therapy.
